UnionStrong® Honors | Innovating Globally, Growing Together — UnionStrong® Named Among China's Top 100 Emerging Global Enterprises of 2026

Recently, CYZone unveiled the 2026 Top 100 Emerging Global Enterprises in Digital Trade at the "Digital Trade Venture Capital Day" during the 5th Global Digital Trade Expo. The ranking recognizes Chinese companies demonstrating strong global growth potential, evaluating them across five key dimensions: international market presence, product competitiveness, business scale, regulatory compliance and operational stability, and brand recognition.

The list features two categories, "Leading Enterprises" and "Growth Enterprises," with the latter highlighting companies that have generated overseas revenue and demonstrated clear global strategies and strong growth potential. UnionStrong® was selected for the Growth Enterprises category, recognizing its proprietary innovations in AI-powered neurovascular care and its potential for international expansion.

As a leading Chinese innovator in AI-powered diagnosis and treatment of neurovascular diseases, UnionStrong® continues to advance its DEEP AI for NEURO comprehensive AI solution for neurovascular diseases. Driven by technological innovation, the company is steadily expanding its international presence, exploring opportunities in technology transfer, product deployment, and integrated clinical services. Through these efforts, UnionStrong® aims to bring the value of China's homegrown medical AI innovations to healthcare markets worldwide.